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Intra-abdominal infections (IAI) continue to be a serious clinical problem. Bacterial synergism is an
important factor that influences the shift from contamination to IAI, leading to the development of lesions and
abscess formation. Escherichia coli and Bacteroides fragilis are particularly abundant in IAI. The underlying
molecular mechanisms of this pathogenic synergy are still unclear. The role of the hemoglobin protease (Hbp)
autotransporter protein from E. coli in the synergy of IAI was investigated. Hbp is identical to Tsh, a
temperature-sensitive hemagglutinin associated with avian pathogenic E. coli. Clinical isolates from miscel-
laneous extraintestinal infections were phenotypically and genotypically screened for Hbp. The presence of
Hbp was significantly associated with E. coli isolated from IAI and other extraintestinal infections. In a murine
infection model, Hbp was shown to contribute to the pathogenic synergy of abscess development. Mice
immunized with Hbp were protected against mixed infections and did not develop abscess lesions. Further-
more, an E. coli wild-type strain that did not induce abscess formation in the synergy model was transformed
with a plasmid encoding the hbp gene, and mixed infections with this strain lead to increased growth of B.
fragilis and induction of abscess lesions. Growth-promoting studies showed that purified Hbp is able to deliver
heme to B. fragilis strain BE1. In conclusion, results suggest the synergy of abscess formation by E. coli and B.
fragilis can be partly explained by the capacity of B. fragilis to intercept Hbp and iron from heme to overcome
the iron restrictions imposed by the host.
Intra-abdominal infections (IAI) in humans due to an ab-
dominal trauma or surgery are a serious clinical problem (1, 4,
9, 11). The mortality rate lies between 5 and 50%, depending
on the anatomic origin of bacterial contamination. IAI may
spread to adjacent tissues or become loculated with abscess
formation. In particular, the abscesses form a serious threat to
the patient. Bacterial leakage from or the rupture of an abscess
can result the sudden entry of a huge number of microorgan-
isms into the host’s circulation. This bacteremia may progress
to sepsis, septic shock, and multisystem organ failure (1, 9).
The mortality of these complications is very high (70%). In-
fected patients often need surgery to stop the advancing spread
of the infection, remove loculated pus, and reestablish suffi-
cient blood flow to deliver appropriate antimicrobial agents to
the infected site. In some cases, abscesses can be drained in
combination with antibiotic treatment.
Since normal intestinal flora consists of many bacterial spe-
cies, the initial microflora at the site of an IAI is polymicrobial.
Despite the complexity of this microflora, only a limited num-
ber of different bacterial species are recovered from an abscess.
In particular, Escherichia coli and the strictly anaerobic Bacte-
roides fragilis are often isolated from these abscesses (3, 4, 9,
11). The frequent presence of these two bacterial species in
abscesses has led to the concept of pathogenic synergy. The
mechanism of the pathogenic synergy between E. coli and B.
fragilis during mixed IAI is poorly understood. Bacterial factors
that may be involved are adherence, interference with host
resistance factors, mutual growth stimulation, cytotoxic sub-
stances, and extracellular enzymes (15). Data from experimen-
tal peritoneal infections showed that the addition of heme or
hemoglobin strongly enhances bacterial growth and mortality
rates (2, 5, 23). This indicates that iron limitation in the peri-
toneal cavity of the host is an important defense mechanism.
Recently, a novel heme-binding protein, termed the “hemo-
globin-binding protease” (Hbp), has been characterized in an
E. coli strain isolated from a wound infection (21). Hbp is
identical to Tsh, a hemagglutinin associated with avian patho-
genic E. coli (8, 22), and represents the first described member
of the SPATE group of the autotransporter proteins (14).
Autotransporters comprise a special group of virulence-asso-
ciated proteins in gram-negative bacteria that exhibit diverse
biological functions. (13). Following export to the periplasm
via what is though to be a Sec-dependent mechanism, these
proteins probably use an autosecretion mechanism for presen-
tation at the bacterial cell surface and in some cases are re-
leased into the extracellular milieu. Hbp scavenges heme from
its environment, interacts specifically with human hemoglobin,
degrades it, and subsequently binds the released heme (21).
This specific heme-binding protein could make heme accessi-
ble for bacterial growth, not only for E. coli, but also possibly
for B. fragilis during mixed infections.
* Corresponding author. Mailing address: Department of Molecular
Microbiology, Institute of Molecular Biological Sciences, De Boele-
laan 1087, 1081 HV Amsterdam, The Netherlands. Phone: 31-20-
4447036. Fax: 31-20-4446979. E-mail: brotto@bio.vu.nl.
† Present address: INRS—Institut Armand-Frappier Microbiologie
et Immunologie, Laval, Quebec, Canada.
5
 o
n
 O
ctober 23, 2012 by VRIJE UNIVERSITEIT
http://iai.asm
.org/
D
ow
nloaded from
 
Increased knowledge of the factors that mediate the synergy
between E. coli and B. fragilis and that contribute to abscess
formation could lead to strategies to prevent and treat IAI and
abscesses. This study demonstrates the important role of Hbp
in the pathogenic synergy between E. coli and B. fragilis in IAI.
We propose that the capacity of B. fragilis to intercept the
heme-saturated Hbp overcomes iron restrictions imposed by
the host and hence contributes to this pathogenic synergy.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. E. coli strains isolated from feces and
miscellaneous extraintestinal sources were obtained from the Academic Hospital
of the Vrije Universiteit. The E. coli strains were identified by the API 20E
system (API S.A., Montalieu Vercieu, France), and the serotypes were deter-
mined at the National Institute for Public Health and Environmental Hygiene
(RIVM), Bilthoven, The Netherlands. E. coli K-12 strain DH5 (GIBCO BRL)
and the plasmids pACYC184 (6) and pBRHbp (21) were used in routine cloning
procedures (27). The characteristics of B. fragilis strain BE1 and the E. coli
strains used in experimental infections are listed in Table 1. The clinical isolates
were maintained on 5% horse blood agar plates (no. 2 agar; Oxoid, Ltd., London,
England) at 4°C and stored as glycerol stocks at30°C. E. coli and B. fragilis BE1
were routinely grown in Luria-Bertani medium (17) and in BM medium (29),
respectively. B. fragilis was grown in an anaerobic jar in an atmosphere of 80%
N2, 10% H2, and 10% CO2. If required, antibiotics were added to the culture
media.
General methods. Recombinant DNA techniques were carried out as de-
scribed previously (27). For Western blotting, anti-Hbp antiserum SN-165 raised
against the NH2-terminal part of Hbp was used (21). Another polyclonal anti-
Hbp antiserum (J40) was raised in rabbit against purified Hbp. Polyclonal im-
munoglobulin G (IgG) was purified from this antiserum by protein A affinity
chromatography (Pharmacia Biotech). The J40 IgG antiserum was used in the
growth experiments with B. fragilis BE1. Colicin V expression of the E. coli
strains was determined as described previously (21).
Cloning of the hbp gene and DNA manipulation. The hbp gene, including its
own HindIII and BamHI restriction sites, was cloned into pACYC184. The
obtained plasmid pACYCHbp was introduced into E. coli DH5 and wild-type
strain EB19. A DNA probe specific for hbp (21) was used for the detection of hbp
in E. coli strains in Southern blot hybridization experiments.
Experimental infections. A skin infection model in mice (29) was used to
investigate the possible role of Hbp in the pathogenic synergism. E. coli strains
and B. fragilis BE1 (Table 1) were cultured and subsequently injected into mice
as described previously (29). The inoculum size for E. coli was 5  106 CFU, and
that for B. fragilis BE1 was 2  108 CFU. Six days after the inoculation, animals
were killed and examined for pus formation. Only mice with pus-containing
abscesses were regarded as positive. Viable bacterial counts from the inoculation
sites were made to determine the clearance of bacteria. Mice were immunized
with purified Hbp before challenge by intraperitoneal injection of 50 g of Hbp
in Freund’s complete adjuvant. After 4 weeks, the mice were boosted with 50 g
of Hbp in Freund’s incomplete adjuvant. Another group of mice was only treated
with adjuvant as a control. A week after the booster, the mice from both groups
were challenged as described above. The titer against Hbp was 1:80,000 in the
Hbp-immunized mice at the time of the challenge.
Growth promotion assays. A preculture of the anaerobic bacterium B. fragilis
BE1 in MA medium (21) supplemented with 0.3% tryptone (MAT–0.3%) and
7.7 M hemin was subcultured in MAT–0.3% for 7 h. This was done to exhaust
the internal heme pool of the cells. In a liquid assay, 25 l of heme-depleted cells
was inoculated in 2 ml of MAT–0.3%. Hemin, apo-Hbp, or holo-Hbp was added,
and after 20 h of anaerobic growth, the optical density at 660 nm (OD660) was
measured. Holo-Hbp was prepared by incubating purified apo-Hbp with hemin
under anaerobic conditions. Under these conditions, Hbp binds heme in a 1:1
molar ratio (unpublished data). Hemin is the oxidized form of heme and tends
to form dimers or larger aggregates in an aerobic environment (10). This was a
rate-limiting factor for Hbp to bind heme. Therefore, reduction of hemin was
necessary for an optimal binding of this molecule to Hbp. The obtained holo-
Hbp was used in the growth studies. In the growth-promoting studies in which
hemin was added, the anaerobic environment readily converted hemin to heme,
in this way making the molecule accessible for apo-Hbp. In a filter assay, MAT–
0.3% agar plates were overlaid with 4 ml of MAT–0.3% soft agar (0.6% agar)
containing 107 CFU of heme-depleted B. fragilis BE1 cells. Paper discs, loaded
with 50 l of a putative growth-promoting agent, were placed on the agar plates.
After 24 h of anaerobic incubation, the surfaces of the growing zones were
calculated by photoimaging with a Fluor-S MultiImager (Bio-Rad Laboratories).
RESULTS
Hbp delivers heme to the anaerobic bacterium B. fragilis. A
possible mechanism that contributes to the synergy is the pro-
vision of essential growth factors by one microbe to the other
(25). In preliminary studies, the culture supernatants of E. coli
EB1 and B. fragilis BE1 were tested for their growth-promoting
capabilities. The culture supernatant of E. coli EB1 promoted
the growth of B. fragilis in a heme-restricted medium (data not
shown). Further analysis of the culture filtrate revealed that a
high-molecular-weight heat-labile factor induced the growth
promotion. In addition, a previous study (21) showed that Hbp
is a heme-binding protein. Therefore, the most likely candidate
for the growth-promoting activity of B. fragilis in vitro is Hbp.
To determine whether Hbp delivers heme to B. fragilis BE1,
growth-promoting studies under anaerobic conditions with pu-
rified apo- and holo-Hbp were carried out. Hbp binds heme in
a 1:1 molar ratio (see Materials and Methods). A special cul-
ture medium (MAT–0.3%) was developed with heme as the
growth-restricting factor for the growth-promoting studies. In
control experiments, B. fragilis was not able to grow in this
medium unless a heme source was added (Fig. 1A). Increasing
amounts of holo-Hbp or heme clearly stimulated the growth of
B. fragilis. Roughly twice the amount of heme in comparison to
holo-Hbp was needed to obtain a similar growth promotion of
the BE1 cultures (Fig. 1A). Apo-Hbp, even in higher molar
concentrations than holo-Hbp, did not promote the growth of
B. fragilis. An anti-Hbp antiserum, J40, was used in the growth
TABLE 1. Bacterial strains used in experimental infections
Strains Origin or source Hbpa Characteristic
E. coli
EB1 (O8:K43) IAI (29)  Synergism with BE1
EB4 (O2:K) Intra-abdominal abscess (29)  Synergism with B. fragilis
7122 (O78:K80) Colisepticemia (avian) (22) b Expression similar to EB1
F274 (O111:K) Normal feces 
EB19 (O18:K5) Colon lavage fluid 
EB19(pACYCHbp) EB19 carrying pACYCHbp  Overexpression of Hbp
LG1522 K-12 strain AN1937 carrying pColV-K30 (31)  Expression similar to EB1
B. fragilis BE1 IAI (29)  Synergism with EB1
a Detection of hbp and its product was verified by Southern blotting and immunoblotting, respectively.
b This strain produces Tsh, a protein that is identical to Hbp.
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experiments to determine if this antiserum has an effect on the
growth promotion of B. fragilis by holo-Hbp. Addition of holo-
Hbp together with 175 nM anti-Hbp antiserum reduced the
growth of BE1 cells considerably. In contrast, the anti-Hbp
antiserum did not induce or inhibit the growth of BE1 in
MAT–0.3% medium alone or supplemented with heme (Fig.
1A). Levels of 100 and 80% inhibition of growth were achieved
with antiserum added to the cultures supplemented with 50 or
100 nM holo-Hbp, respectively (Fig. 1A). With larger amounts
of holo-Hbp (200 and 400 nM) growth was reduced 22 to 13%,
respectively. Apparently, heme is not spontaneously released
from the protein during the incubation period. Also, it implies
the need for a specific interaction between BE1 cells and holo-
Hbp in order to release heme from the protein. One remark-
able finding is the 80% inhibition of growth at an approxi-
mately 2:1 ratio of antibody to Hbp, indicating that already two
molecules of antibody could inhibit 1 molecule of protease. At
antibody/Hbp ratios of 1:1 and 1:2, 20 and 10%, respectively,
inhibition was achieved. Extrapolation of these data should
give 40% inhibition instead of the 80% inhibition at the 2:1
ratio of antibody to Hbp. An explanation for the strong inhib-
itory effect of the antibody could be the stressful growth con-
ditions for B. fragilis in MAT–0.3% medium, especially at low
heme concentrations (200 pmol), like those in the cultures
supplemented with 50 or 100 nM holo-Hbp. Therefore, small
changes in the heme availability in these cultures could have a
dramatic effect on the growth of bacteria.
The results of the liquid assay showed that B. fragilis was able
to use holo-Hbp very efficiently as a source of heme. A filter
assay was used to test the ability of apo-Hbp to capture heme
and subsequently donate it to B. fragilis during the growth of
this microorganism. A dose-dependent growth promotion was
observed with apo-Hbp plus heme in the paper discs (Fig. 1B).
Holo-Hbp-loaded discs also induced growth in this assay. Apo-
Hbp alone at the same molar concentrations induced no
growth at all, while only heme-loaded paper discs resulted in a
moderate growth. A mixture of denatured apo-Hbp and heme
provided a growth-promoting activity that was similar to
growth in the presence of heme alone, indicating that a native
conformation of Hbp is required for efficient heme transfer to
B. fragilis.
Hbp is involved in the formation of abscesses. Bacterial
synergism in abscess formation has been demonstrated in sev-
eral animal models (4, 20, 29). The role of Hbp in bacterial
synergism was investigated by screening E. coli strains (Table
1) for their capacity to induce a synergistic interaction with B.
fragilis in a mouse model (29). In this model, it is possible to
test the role of bacterial factors that in vitro experiments sug-
gest are relevant. A synergy between the organisms is demon-
strated when abscesses are present 6 days after inoculation. In
addition, high numbers (106) of bacteria of both species are
typically isolated from the abscesses in a ratio of approximately
1:1.
Infections with any of the E. coli strains or B. fragilis BE1
alone failed to induce abscesses, and only low numbers of
bacteria (5,000 CFU) were recovered from the sites of in-
fection 6 days after inoculation (data not shown). Mixed infec-
tions with either E. coli strain EB1 or EB4 and B. fragilis BE1
resulted in abscess formation, and large numbers of bacteria
were present in these abscesses (Fig. 2A). These Hbp-positive
E. coli strains were previously isolated from IAI (Table 1). The
avian pathogenic strain 7122 produces Tsh, a protein that is
identical to Hbp (22). This strain was able to induce the for-
mation of abscesses, although the number of bacteria recov-
ered from these abscesses was lower than the number of bac-
teria isolated for strain EB1 or EB4 (Fig. 2A). Thus, only the
combination of B. fragilis and Hbp-positive E. coli strains in-
duced the formation of abscesses. However, among the Hbp-
positive strains, a significant difference in the number of bac-
teria recovered from the abscesses was observed (Fig. 2A).
This is due to the fact that these E. coli strains induced the
formation of abscesses of different sizes. E. coli EB1 together
with B. fragilis BE1 induced the formation of abscesses of
approximately 84 mm2 in size, while mixed infections with EB4
or 7122 revealed abscesses of 26 or 18 mm2 in size, respec-
tively. Larger abscesses contain higher numbers of bacteria
than smaller abscesses. These results indicate that, besides
Hbp, other strain-specific properties of E. coli play a role in the
FIG. 1. Growth stimulation of B. fragilis BE1 by Hbp under heme-
restrictive conditions. (A) Growth of BE1 cells in 2-ml cultures. Heme-
depleted cells were inoculated in MAT–0.3% medium supplemented
with apo-Hbp or holo-Hbp. Cultures supplemented with only heme or
with no extra additions were used as positive and negative growth
controls, respectively (see Materials and Methods for details). The
arrows indicate the obtained growth of the 2-ml cultures in the pres-
ence of 175 nM anti-Hbp antiserum J40. The OD660 was measured
after 20 h. Data represent means  standard deviations of five inde-
pendent experiments. (B) Ability of Hbp to donate heme to B. fragilis.
Paper discs were loaded with an increasing concentration of heme and
apo-Hbp. The 50-l samples on the discs were placed on agar plates
inoculated with heme-depleted BE1 cells. The surfaces of the growth
zones around the discs were measured after 24 h of growth. Apo-Hbp
alone and holo-Hbp were used as negative and positive growth con-
trols, respectively. The values of the growth zones around the discs are
expressed in square millimeters. Four independent growth measure-
ments were conducted, producing essentially identical results.
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formation and final size of an abscess. No bacterial synergy
between B. fragilis strain BE1 and either of the Hbp-negative
E. coli strains F274 or EB19 was detected. E. coli K-12 strains
carrying hbp or pColV-K30, which encodes Hbp (Table 1),
were also tested in this model. None of these strains showed a
synergistic interaction with B. fragilis, and only low numbers of
either bacterial species (5,000 CFU) were recovered from
the site of inoculation (data not shown). Thus, neither Hbp nor
any of the virulence-associated properties encoded on pColV-
K30 significantly enhanced abscess formation in mice by E. coli
K-12.
To determine whether Hbp has a critical role in abscess
formation, mice were immunized with Hbp and were then
challenged with a mixed infection of BE1 and EB1. Another
group of mice was only treated with adjuvant before the chal-
lenge. Abscess formation was prevented by this immunization
(Fig. 2B). Following the challenge, a significant decrease in the
number of both bacterial species was observed at the site of
inoculation in Hbp-vaccinated mice (Fig. 2B). To examine the
influence of Hbp on abscess formation in mixed infections, the
Hbp-negative wild-type E. coli strain EB19 was transformed to
an Hbp-positive phenotype (Table 1). As shown in Fig. 2B, the
combination of strain EB19(pACYCHbp) with BE1 induced
abscesses, in contrast to the combination of strain EB19 with B.
fragilis BE1. Remarkably, a significant increase in the number
of B. fragilis cells in mixed infections with strain
EB19(pACYCHbp) was observed, whereas similar levels of E.
coli cells were recovered from the inoculation sites following
infection with either strain EB19 or strain EB19(pACYCHbp).
It appears that strain EB19(pACYCHbp) cannot use Hbp for
its own benefit, possibly due to the lack of a specific Hbp
receptor. These results indicate that Hbp is a contributing
factor for the growth of B. fragilis in vivo and for the synergistic
development of abscess formation in the mouse model.
Prevalence of Hbp-positive E. coli among strains isolated
from mixed IAI. If Hbp contributes to the pathogenesis of IAI,
then this would predict a high prevalence of Hbp-positive
strains among E. coli isolated from IAI should be expected. To
test this hypothesis, clinical isolates from extraintestinal infec-
tions, including IAI, urinary tract infections, and bacteremia,
were phenotypically and genotypically screened for Hbp. For
comparison, E. coli isolates from feces of healthy individuals
were also examined for Hbp. This screening clearly revealed a
high frequency of Hbp-positive E. coli among strains from IAI
(Table 2). The overall incidence of Hbp-positive strains iso-
lated from extraintestinal infections was 31%; it varied from
20% for blood, to 17% for urine, to 57% for strains isolated
from IAI. In contrast, only 1 of 22 strains isolated from normal
enteric flora was Hbp positive, indicating that Hbp is associ-
ated with extraintestinal infections, especially with IAI (Table
FIG. 2. Experimental infections in mice. (A) Numbers of E. coli
and B. fragilis BE1 cells at the sites of infection 6 days postinoculation
with a mixture of both species. (Inset) Significance levels among the
numbers of bacteria of the different strains. (B) Numbers of EB1 and
BE1 after a challenge in immunized or sham-immunized mice and the
numbers of EB19, EB19(pACYCHbp) and BE1 6 days postinoculation
with a mixture of both species. The sham-immunized and Hbp-immu-
nized groups of mice are indicated as 	 and 
, respectively. The
significance levels among the numbers of EB1 or BE1 cells from
immunized or sham-immunized mice and the levels between the num-
ber of EB19 or EB19(pACYCHbp) cells together with BE1 were
determined. Each column represents the mean of at least six samples,
and bars indicate the standard error of the mean. The significance of
the difference is indicated as * at 0.01  P  0.05, ** at 0.001  P 
0.01, and *** at P  0.001, as tested by analysis of variance. Abscess
formation in mice on day 6 following bacterial inoculation is indicated
by minus signs for no abscesses and plus signs for abscesses.
TABLE 2. Incidence of Hbp, colicin V, and hemolysin
among E. coli strains
Source of strainsa
(no. tested)
% of strains producing:
Hbpb Colicin V Hemolysin
Blood (25) 20 40 44
Urine (18) 17 22 33
Intra-abdomen
(IAI) (21)
57 38 24
Total extraintestinal (64) 31 34 34
Normal feces (22) 5 18 14
a Blood included E. coli isolates from sepsis, septic shock, carcinomas, and
acute myeloid leukemia. Urine included urinary tract infections and urosepsis.
Intra-abdomen included abscesses, wounds, appendicitis, and peritonitis.
b Significant difference in the incidence of Hbp between E. coli strains isolated
from extraintestinal infections and those isolated from normal feces (Fisher’s
exact test, P  0.016), and in the prevalence of Hbp from IAI versus other
extraintestinal infections (P  0.005).
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2). There was no prevalent serotype among the Hbp-positive E.
coli strains isolated from IAI (data not shown).
All strains were evaluated on blood agar plates for hemolytic
activity and were also tested for colicin V. The incidences of
hemolytic strains from IAI, urine, and blood were 24, 33, and
44%, respectively. In contrast, only 14% of the strains isolated
from feces were hemolytic (Table 2). Only 3 out of the 12
Hbp-positive strains from IAI showed hemolytic activity, while
the 5 Hbp-positive strains from blood were all positive for
hemolysin (data not shown). A higher prevalence for colicin
V-producing E. coli was found among strains from blood and
IAI compared with strains from urine and feces (Table 2). Six
of the 12 Hbp-positive strains from IAI were also positive for
colicin V (data not shown), indicating that Hbp is not always
associated with the production of colicin V.
DISCUSSION
The results of our study confirm earlier observations (18, 30,
31) that hemolysin and colicin V are associated with E. coli
isolates from extraintestinal infections. Moreover, we found
that Hbp is clearly correlated with these types of infections and
is significantly more prevalent in IAI than in other extraintes-
tinal infections. A clear relationship between Hbp and colicin
V or hemolysin in IAI was not found.
The mechanism of the pathogenic synergy between E. coli
and B. fragilis in IAI is poorly understood. Factors that might
contribute to synergy are anaerobic conditions produced by E.
coli, inhibition of chemotaxis, phagocytosis and killing of E.
coli by factors from B. fragilis (26), and provision of growth
factors (9, 12, 15, 20). Herein, we have demonstrated that Hbp
contributes to this synergy, since only the combination of B.
fragilis and Hbp-positive E. coli strains induced abscesses. It
should be noted that the number of bacteria still present in
abscesses and the sizes of the abscesses 6 days after inoculation
was dependent on the E. coli strain used. This indicates that
besides Hbp, other strain-specific properties of E. coli play a
role in the pathogenesis of IAI.
The results of the growth-promoting studies showed that
Hbp is capable of delivering heme to B. fragilis and that a
native conformation of Hbp is required for an efficient heme
transfer. In addition, heme was not spontaneously released
from Hbp in the growth-promoting experiments, because 100
to 80% of growth inhibition was obtained with specific anti-
Hbp antiserum. A possible leakage of heme from Hbp during
these experiments should give growth comparable to that in
the cultures supplemented with heme alone (Fig. 1). There-
fore, these results suggest the presence of a specific receptor at
the B. fragilis cell surface to internalize the heme from Hbp.
The use of a heme-binding protein of one bacterial species by
another species has not been observed before. Such an inter-
changeable usage of iron-binding molecules has only been pre-
viously described for siderophore-mediated iron uptake sys-
tems (7, 16).
Hemolysins can make hemoglobin accessible for Hbp-pro-
ducing E. coli by lysing erythrocytes, and, therefore, a strong
correlation between hemolysin and Hbp was expected among
strains from IAI. However, such a correlation was not found.
In contrast, among E. coli strains isolated from blood, all Hbp-
positive strains produced hemolytic activity, suggesting that
hemolysin production is more important for E. coli associated
with mono infections of bacteremia than for E. coli strains
associated with mixed IAI. Possibly during IAI, B. fragilis
makes hemoglobin accessible for Hbp-positive E. coli by lysing
erythrocytes. Consistently, it is well known that Bacteroides
spp. produce hemolysin (15), including B. fragilis strain BE1
used in this study.
We have demonstrated a role for Hbp in the formation of
abscesses. A previous study has shown that the capsular poly-
saccharide of B. fragilis promotes the formation of abscesses
(28). We hypothesize that in the presence of Hbp B. fragilis can
more readily acquire iron from heme and grow at the site of
infection. Hbp is likely used for iron acquisition by B. fragilis
during the early stage of a mixed infection. Due to improved
growth, increased amounts of capsular polysaccharide may be
produced by this anaerobe and could promote the formation of
abscesses. In addition, short-chain fatty acids secreted by B.
fragilis inhibit the killing of E. coli by neutrophils (26). The
inhibition of neutrophil function by the growing B. fragilis in its
turn benefits E. coli, accelerating in this way the process of
abscess formation. The abscesses shelter the microorganisms
from circulating host defense mechanisms (24).
Tsh, a protein that is identical to Hbp, was identified as a
hemagglutinin of an avian pathogenic E. coli strain recently
isolated (22). In a recent report (8), there was a clear correla-
tion between the presence of tsh, and the virulence of avian
pathogenic E. coli strains as well as an association and linkage
between tsh and colicin V genes encoded on plasmids. The
results of this report also suggested that Tsh might contribute
to the pathogenesis of early stages of colisepticemia within the
avian respiratory tract. We have screened 26 isolates from
affected hearts of diseased chickens with E. coli septicemia
phenotypically and genotypically for Hbp and colicinV, and
65% of the strains appeared to be positive for both of these
properties (data not shown). It seems that Hbp (Tsh) contrib-
utes to at least two different infectious diseases: IAI in humans
and respiratory tract infections in poultry.
Identification of molecular interactions in host-microbe and
microbe-microbe relationships in IAI is a crucial first step in
order to develop novel antimicrobial strategies, especially at a
time that resistance to antibiotics is a significant and growing
clinical problem (1, 19). The results presented here define
mechanisms that could be used to develop novel therapeutic
targets at the level of protein interactions between infecting
pathogens and their host in IAI. In the present study, mice
immunized with Hbp were protected against the formation of
abscesses following challenge with an Hbp-positive E. coli
strain and B. fragilis strain that synergize and readily induce
abscesses in naive unimmunized mice. Possible modes of this
inhibition of abscess formation may be a general neutralization
of Hbp, just like what was observed in the in vitro growth
assays with B. fragilis, or the E. coli bacterium may be killed by
an immune response to Hbp associated with the bacterial cell
surface. The presence of cell surface-associated Hbp in E. coli
was tested (21). It appears that the wild-type strain EB1 very
efficiently processed Hbp, and no cell surface-associated Hbp
was detected. K-12 strains that overexpress Hbp are less effi-
cient in the processing of this protein, and cell surface-exposed
Hbp can be detected, especially at lower growth temperatures
(data not shown). Furthermore, the results of the experimental
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infections with strain EB19(pACYCHbp) clearly suggest that
the induction of abscess formation is due to the presence of the
hbp gene encoded on a plasmid (Fig. 2A). These results sup-
port a role for Hbp in the synergy of abscess formation in vivo
that correlates with the increased growth of B. fragilis BE1 in
vitro under heme-limiting conditions. In conclusion, it is likely
that a general neutralization of Hbp by antibodies is respon-
sible for the protection against the formation of abscesses.
Further studies will be directed at the possible targets for the
development of new treatments against IAI, which include the
proteolytic, heme-binding, and receptor domains of Hbp, as
well as the putative cell surface-exposed Hbp receptors of E.
coli and B. fragilis.
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